Evogene Ltd.

Proxy Solicitation & Information Statement • Sep 5, 2022

Exhibit 99.3

EVOGENE LTD.

PROXY FOR THE 2022 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 8, 2022 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned hereby consitiutes and appoints Nisan, and each of them, the tree and lawful attomeys, agents and proxies of the undersigned, with fill prover of substitution to each of them, to represent and to vote undersiged, all of the Ordinary Shares, par value 0.02 Vev Israeli Shekels, of Erogene Ltd. (the "Company") held of record in the name of the undersigned at the close of business on August of Sharbiolors, as it may be adjurned from inne to ime (the "Needing") to be led at the executive of the Company, 13 Gal Feinvot, Rehovot, Rehovot, Israel, on Thursday, September 8, 2022 at 3:00 p.m. (Israel time), and any and all adjourments or pestporents thereof, on the filly described in the Notice of 2022 Amual Geneal Meeting of Shareholders and Proxy Statement of the Company relating to the Meeting (the "Proxy Statement").

This proxy, when properly executed, will be namer directed herein by the undersigned. If to direction is made with respect to any proposal, this proxy will be voted POR each such proposal and in such manner as the proxy may determine with respect o any other the Medies as may properly come before the Medine or postponements thereof.

Any and all proxies heretofore given by the undersigned are hereby revoked.

(Continued and to be signed on the reverse side)

ANNUAL GENERAL MEETING OF SHAREHOLDERS OF

EVOGENE LTD.

September 8, 2022

Please date, sign and mail your proxy card in the envelope provided as soon as possible.

ل Please detach along perforated line and mail in envelope.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" ALL PROPOSALS LISTED BELOW. PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE B

	FOR	AGAINST	ABSTAIN
1. Re-election or election of each of the below-listed directors, until the Company's next annual general meeting of shareholders and until his or her successor is duly elected and qualified:
(a) Ms. Sarit Firon		D
(b) Dr. Adrian Percy	D	0	0
(c) Mr. Leon Y. Recanati	0	L	L
(d) Prof. Oded Shoseyov	0	ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ	L
(e) Mr. Dan Falk	0	ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ	L
(f) Mr. Nir Nimrodi		L	L
2. To approve a reverse share split of the Company's ordinary shares in the range of 2:1 up to 10:1, to be effected at the discretion of, and at such ratio and in such date as shall be determined by, the Board of the Company, within 12 months of the Meeting; and to amend the Company's Articles of Association accordingly.	0	ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ	ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ
3. Approval of the re-appointment of Kost Forer Gabbay & Kasierer, registered public accounting firm, a member firm of Ernst & Young Global, as the Company's independent registered public accounting firm for the year ending December 31, 2022 and until the Company's next annual general meeting of shareholders, and the authorization of the Board of Directors of the Company or the audit committee thereof to fix such accounting firm's annual compensation.	0	ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ	L
To change the address on your account, please check the box below and indicate your new address in the space provided below. Please note that changes to the registered name(s) on the account

Signature of shareholder Date Signature of shareholder Date

may not be submitted via this method.

Note . Please sign exactly as your names appear on this Proxy. When shares are held jointly, each owner should sign. When signing as executor, administrator, attorney, trust guardian, please give full title as such. If the signer is a corporate name by a duly authorized officer, gring full title as such. If the signer is a partnership, please sign in partnership name by authorized person.